Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica E Pittman

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 18, 2006
Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomographyDelphine L Chen, Thomas W Ferkol, Mark A Mintun, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 9, 2022
Impact of azithromycin on serum inflammatory markers in children with cystic fibrosis and new PseudomonasJessica E Pittman, Michelle S Skalland, Scott D Sagel, et al.
Annals of the American Thoracic Society|June 14, 2016
Pediatric Pulmonary HypertensionDebra Boyer, Jessica E Pittman, Fei Jamie Dy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 17, 2009
Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndromeMargaret W Leigh, Jessica E Pittman, Johnny L Carson, et al.
Plos One|May 16, 2017
Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infectionJessica E Pittman, Hannah Noah, Hollin E Calloway, et al.
Pediatric Pulmonology|January 4, 2011
Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung diseaseJessica E Pittman, Elizabeth H Calloway, Michelle Kiser, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 18, 2026
Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children ≥2 years with cystic fibrosis: 96-week interim results from a phase 3 open-label extension studyJennifer L Goralski, Cori Daines, Jessica E Pittman, et al.
Annals of the American Thoracic Society|June 20, 2025
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in 6 to 11-Year-Olds with Cystic FibrosisJessica E Pittman, Sarah Morgan, Morgan McCreary, et al.
Annals of the American Thoracic Society|July 15, 2017
Association of Antibiotics, Airway Microbiome, and Inflammation in Infants with Cystic FibrosisJessica E Pittman, Kristine M Wylie, Kathryn Akers, et al.
Annals of the American Thoracic Society|June 16, 2015
Multiple-Breath Washout as a Lung Function Test in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop ReportPadmaja Subbarao, Carlos Milla, Paul Aurora, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
American Journal of Respiratory and Critical Care Medicine|March 18, 2006
Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomographyDelphine L Chen, Thomas W Ferkol, Mark A Mintun, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 9, 2022
Impact of azithromycin on serum inflammatory markers in children with cystic fibrosis and new PseudomonasJessica E Pittman, Michelle S Skalland, Scott D Sagel, et al.
Annals of the American Thoracic Society|June 14, 2016
Pediatric Pulmonary HypertensionDebra Boyer, Jessica E Pittman, Fei Jamie Dy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 17, 2009
Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndromeMargaret W Leigh, Jessica E Pittman, Johnny L Carson, et al.
Plos One|May 16, 2017
Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infectionJessica E Pittman, Hannah Noah, Hollin E Calloway, et al.
Pediatric Pulmonology|January 4, 2011
Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung diseaseJessica E Pittman, Elizabeth H Calloway, Michelle Kiser, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 18, 2026
Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children ≥2 years with cystic fibrosis: 96-week interim results from a phase 3 open-label extension studyJennifer L Goralski, Cori Daines, Jessica E Pittman, et al.
Annals of the American Thoracic Society|June 20, 2025
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in 6 to 11-Year-Olds with Cystic FibrosisJessica E Pittman, Sarah Morgan, Morgan McCreary, et al.
Annals of the American Thoracic Society|July 15, 2017
Association of Antibiotics, Airway Microbiome, and Inflammation in Infants with Cystic FibrosisJessica E Pittman, Kristine M Wylie, Kathryn Akers, et al.
Annals of the American Thoracic Society|June 16, 2015
Multiple-Breath Washout as a Lung Function Test in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop ReportPadmaja Subbarao, Carlos Milla, Paul Aurora, et al.
Pageof 4